PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Hematology, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Harvard Medical School, Boston, Massachusetts, USA.\', \'Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/ajh.25962
?:hasPublicationType
?:journal
  • American journal of hematology
is ?:pmid of
?:pmid
?:pmid
  • 32780525
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.092
?:rankingScore_hIndex
  • 88
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19).
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all